Blog

CReDO for early career cancer researcher

Photo from Pramesh CS/X

Sep 3, 2024, 13:56

CReDO for early career cancer researcher

Pramesh CS, Director at Tata Memorial Hospital, shared a post on X:

“If you are an early career cancer researcher, do apply for the CReDO, National Cancer Grid.

Convert your research idea into a full-fledged protocol ready for Ethics submission.

Opportunity to be mentored by the best cancer research faculty in the world.

CReDO is supported by NCI, NCI Center for Global Health, St. Jude Children’s Research Hospital, ASCO, World Health Organization South-East Asia, City Cancer Challenge, IAEA, MRC Clinical Trials Unit at UCL, King’s College London, The Lancet Oncology, Nature Reviews Clinical Oncology, R4HC-MENA.

Held under auspices of EORTC.

Details.

Apply online.”

Source: Pramesh CS/X

More posts by Pramesh CS on oncodaily.com

ASCO cancer City Cancer Challenge CReDO EORTC IAEA King's College London MRC Clinical Trials Unit at UCL National Cancer Grid Nature Reviews Clinical Oncology NCI NCI Center for Global Health OncoDaily Oncology Pramesh CS R4HC-MENA St. Jude Children's Research Hospital Tata Memorial Hospital The Lancet Oncology World Health Organization South-East Asia

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage